{'fraction_non_alphanumeric': 0.03235990528808208, 'fraction_numerical': 0.026045777426992895, 'mean_word_length': 4.87037037037037, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
THE CORRELATION BETWEEN COGNITIVE DECLINE AND THE INCIDENCE AND THE INFLUENCE OF METABOLIC SYNDROME IN ELDERLY SUBJECTS WITH MILD COGNITIVE DECLINE

Introduction: The leading causes of irreversible cognitive impairment of late life are Alzheimer disease (AD) and vascular cognitive impairment, vascular dementia (VD). Purpose: To evaluate the incidence and the influence of the metabolic syndrome and metabolic syndrome components on a third age population with mild cognitive impairment and no prior history of cognitive decline. Material and method: The subjects included in this study were admitted in the ER and the Neurology Clinic of "Vasile Goldis" Western University of Arad during a period of 4 years, beginning with 2004. 198 subjects qualified the inclusion/exclusion criteria set for this study. Results: Most of the included subjects were men (56.57%). The average age was 68.3 +/- 4.5 years. The incidence of the MetSy in the study group was 39.39. The most significant cognitive decline is associated to the presence of HTA, leukoaraiosis and age with a mean decrease in MMSE score of -4.556, - 4.235 and -3.568. Conclusions: Mild cognitive impairment is more frequent and significantly associated to metabolic syndrome and other vascular risk factors.